Diseases that Harm Require Therapies that Harm Less---Sir William Osler（1849-1919)
On July 9, the sub-forum “Minimally Invasive and Noninvasive Treatment for Gynecological Diseases” of The Fifth Yangtze International Summit of Minimally Invasive and Noninvasive Medicine & 2023 “One Belt One Road” Innovation Forum on Minimally Invasive and Noninvasive Medicine was held successfully.
This sub-forum was co-chaired by Mustafa M.M. Aldam, Founder and President of the international association of cosmetic gynecology, Huang Yan, Director of Gynecology Department of Qiannan People's Hospital, and Li Meifang, Head of Breast Disease Diagnosis and Treatment Center of the First Affiliated Hospital of Jiangxi Medical College. A total of 6 experts focused on "minimally invasive and noninvasive treatment for gynecological diseases" and shared their brilliant lectures, discussing the minimally invasive and noninvasive treatment of gynecological diseases such as early-stage cervical cancer, mammary fibroadenoma, pelvic adhesion, and so on.
Yang Linqing, Chief Physician of Affiliated Hospital of Jining Medical College, shared a lecture on “Robotic laparoscopic strategy for management of deep endometriosis”. Deep infiltrating endometriosis (DIE) is a disease that requires long-term management. Its surgery should pay attention to preoperative, intraoperative, and postoperative management and its treatment requires MDT teamwork. In that case, Robotic management of DIE has obvious advantages and can be a recommended procedure.
Yang Hongwei, Chief Physician of Breast and Thyroid Surgery, Suining Central Hospital, shared a special lecture on “Study on the effectiveness and safety of HIFU in the treatment of breast fibroadenoma”. Advantages of HIFU treatment for breast fibroadenoma: 1. non-invasive treatment: no trauma, no risk of bleeding and infection, no incision scar on the skin; 2. real-time monitoring, conformal ablation; 3. local anesthesia operation, short treatment time; 4. one-time treatment of multiple lesion, repeatable treatment, especially suitable for multiple or recurrent breast fibroadenomas; 5. no radiation and chemical damage.
Dr. Zhu Lin, Chief Physician of the Second Hospital of Shandong University, shared a lecture on “Tumor-free operation and parametrial management in laparoscopic surgery for early stage cervical cancer”. LRH without uterus manipulator is completely feasible with good preoperative evaluation: staging, imaging, and self-assessment. Understand treatment principles of FIGO staging and NCCN guidelines. He emphasized that physicians must understand the hysterectomy QM subtypes and its range of application, and carefully select cases of C1 and cervical extensive; master the learning curve and don't overstep and put the patient's interests first.
Xia Tiansong from Jiangsu Provincial People's Hospital shared a lecture on “Focused ultrasound ablation surgery for the treatment of breast tumors”. Exploration towards early breast cancer, locally advanced breast cancer, and breast fibroid treatment were made from three perspectives: effectiveness, safety, and maneuverability.
Xiao Ziwen, Chief Physician, Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, gave a lecture on “the exploration of surgery method for stress incontinence”. He answered these questions: For traction of adhesions, why not use scissors to change the traction position to maintain sufficient tension.? Why not use a uterine manipulator when pushing the uterus, fallopian tubes, and ovaries,? And he shared his experience with laparoscopic separation of pelvic adhesions.
Zhang Cai, Head of Medical Research Department of National Engineering Research Center of Ultrasound Medicine, shared “Comparison of cosmetic outcomes and cost-effectiveness among different treatments for breast fibroadenoma”. She concluded that in the HIFU group, a greater number of lesions are treated in a single session, a higher rate of complete treatment of multiple lesions is reached, and a shorter treatment time for individual lesion is needed, and no postoperative adverse events. Patients in the HIFU group showed improvement in postoperative physical and psychological conditions compared with preoperative conditions. Compared with VABB, HIFU has lower cost and higher utility; Compared with OS, although HIFU has higher costs, it achieves higher utility and the ICUR is within an acceptable and reasonable range